John Turk, MD, PhD, was a pioneer in lipid biochemistry, defining key mechanisms of phospholipid signaling that contribute to diabetes. His work first drew international attention when he used tandem mass spectrometry to determine the molecular structures of complex lipids such as phosphatidylcholines, one of the fundamental lipid building blocks of cells.
Dr. Turk was among the discoverers of the key calcium-independent phospholipase A2, iPLA2b, that participates in the control of insulin secretion and the survival of pancreatic beta cells.
Friends and colleagues of John Turk, MD, PhD, are sponsoring the Travel Award for a Postdoctoral Fellow and Graduate Student in conjunction with the Bioactive Lipids Conference. Applicants must be presenting work in the area of phospholipase A2 or other phospholipases.
Application and recommendation letters must be sent via email
Submission deadline date: August 26, 2022